CIK 0000310158
- Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 221918501
- Phone
- +1 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,611,875
- in 1 filing
Net −$8,611,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise | +59,564 | 196,541.14 | ||
| 2022-10-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise | +104,993 | 301,534.14 | ||
| 2022-10-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Sale | −164,557 | $100.26 | $16.5M | 136,977.14 |
| 2022-10-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise · Stock Option (Right to Buy) | −59,564 | 0 | ||
| 2022-10-28 | DeLuca Richard R. EVP&Pres, Merck Animal Heallth | Option exercise · Stock Option (Right to Buy) | −104,993 | 0 | ||
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Option exercise | +567,084 | 1,273,367.06 | ||
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Sale | −75,489 | $99.15 | $7.5M | 1,197,878.06 |
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Sale | −313,232 | $100.25 | $31.4M | 884,646.06 |
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Sale | −178,363 | $100.80 | $18.0M | 706,283.06 |
| 2022-10-28 | FRAZIER KENNETH C Executive Chair | Option exercise · Stock Option (Right to Buy) | −567,084 | 0 | ||
| 2022-10-28 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise | +16,997 | 58,099.97 | ||
| 2022-10-28 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise | +15,000 | 73,099.97 | ||
| 2022-10-28 | Karachun Rita A Sr. VP Fince-Global Controller | Sale | −31,997 | $100.34 | $3.2M | 41,102.97 |
| 2022-10-28 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise · Stock Option (Right to Buy) | −16,997 | 0 | ||
| 2022-10-28 | Karachun Rita A Sr. VP Fince-Global Controller | Option exercise · Stock Option (Right to Buy) | −15,000 | 15,875 | ||
| 2022-10-28 | MIZELL STEVEN EVP, Chief HR Officer | Option exercise | +17,000 | 57,144.15 | ||
| 2022-10-28 | MIZELL STEVEN EVP, Chief HR Officer | Sale | −17,000 | $100.00 | $1.7M | 40,144.15 |
| 2022-10-28 | MIZELL STEVEN EVP, Chief HR Officer | Sale | −8,000 | $98.84 | $791K | 32,144.15 |
| 2022-10-28 | MIZELL STEVEN EVP, Chief HR Officer | Option exercise · Stock Option (Right to Buy) | −17,000 | 35,824 | ||
| 2022-10-28 | Oosthuizen Johannes Jacobus President, U.S. Market | Sale | −3,633 | $100.21 | $364K | 10,880.88 |
Page 32 of 42 · 823 trades